Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390827 · ClinicalTrials.gov registry record
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
A clinical trial of Solid Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 3,644
- Enrollment target
- 1
- Study location
NCT05390827: Recruiting study of Solid Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05390827 is a study of Solid Tumor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3,644 participants, above the 203-participant average among 196 other Solid Tumor trials with a reported enrollment target (1695% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05390827, a study of Solid Tumor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 3,644 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
Primary Outcome
to create a repository and infrastructure to address novel questions of clinical importance.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,644 participants |
| Start Date | 2022-05-19 |
| Est. Completion | 2027-07 |
What NCT05390827 shows while recruiting
NCT05390827 is an observational study that tracks outcomes without assigning an intervention. Its 3,644 participants enrollment target places it among the larger protocols in the corpus, above the 203-participant average among 196 other Solid Tumor trials with a reported enrollment target (1695% higher).
The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT05390827 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05390827 about?
NCT05390827 is a clinical study titled "Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol". The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead ...
What is the current status of trial NCT05390827?
This trial is currently recruiting. The enrollment target is 3,644 participants. The study started on 2022-05-19. Estimated completion is 2027-07.
What conditions does trial NCT05390827 study?
This clinical trial studies the following conditions: Solid Tumor.
Who is sponsoring clinical trial NCT05390827?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05390827 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05390827's enrollment target sits among peer trials
3,644 3rd of 196 higher than 194 of 196 other Solid Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
- NCT07249398 · 3,650 participants · NA
Influence of Social Media Ads on Food Choice - Master Protocol
- NCT06354920 · 3,624 participants · NA
M-Well Bonding Bundle to Improve Patient-Physician Relationships
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI